CURIOSITYSTREAM INC (CURI)
US23130Q1076 - Common Stock
We assign a fundamental rating of 3 out of 10 to CURI. CURI was compared to 72 industry peers in the Entertainment industry. While CURI seems to be doing ok healthwise, there are quite some concerns on its profitability. CURI is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CURI has reported negative net income.
CURI had a positive operating cash flow in the past year.
CURI had negative earnings in each of the past 5 years.
In the past 5 years CURI always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -16.89%, CURI is not doing good in the industry: 78.87% of the companies in the same industry are doing better.
The Return On Equity of CURI (-23.77%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.89% | ||
| ROE | -23.77% | ||
| ROIC | N/A |
ROA(3y)-32.91%
ROA(5y)-33.84%
ROE(3y)-44.62%
ROE(5y)-54.51%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 48.40%, CURI is in line with its industry, outperforming 59.15% of the companies in the same industry.
In the last couple of years the Gross Margin of CURI has declined.
CURI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 48.4% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15%
GM growth 5YN/A
2. Health
2.1 Basic Checks
CURI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CURI has more shares outstanding
There is no outstanding debt for CURI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of -2.44, we must say that CURI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -2.44, CURI is not doing good in the industry: 83.10% of the companies in the same industry are doing better.
There is no outstanding debt for CURI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | -2.44 |
ROIC/WACCN/A
WACC9.05%
2.3 Liquidity
CURI has a Current Ratio of 1.90. This is a normal value and indicates that CURI is financially healthy and should not expect problems in meeting its short term obligations.
CURI has a Current ratio of 1.90. This is in the better half of the industry: CURI outperforms 70.42% of its industry peers.
A Quick Ratio of 1.90 indicates that CURI should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.90, CURI is in the better half of the industry, outperforming 73.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.9 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 75.00% over the past year.
The Revenue has decreased by -8.56% in the past year.
Measured over the past years, CURI shows a quite strong growth in Revenue. The Revenue has been growing by 12.82% on average per year.
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88%
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y12.82%
Revenue growth 5YN/A
Sales Q2Q%-19.36%
3.2 Future
CURI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.98% yearly.
Based on estimates for the next years, CURI will show a small growth in Revenue. The Revenue will grow by 7.98% on average per year.
EPS Next Y75.51%
EPS Next 2Y37.49%
EPS Next 3Y27.13%
EPS Next 5Y25.98%
Revenue Next Year-12.99%
Revenue Next 2Y-2.55%
Revenue Next 3Y2.22%
Revenue Next 5Y7.98%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CURI. In the last year negative earnings were reported.
Also next year CURI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
83.10% of the companies in the same industry are more expensive than CURI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CURI is valued a bit cheaper than 76.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.85 | ||
| EV/EBITDA | 4.7 |
4.3 Compensation for Growth
CURI's earnings are expected to grow with 27.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.49%
EPS Next 3Y27.13%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.13%, CURI is a good candidate for dividend investing.
CURI's Dividend Yield is rather good when compared to the industry average which is at 3.61. CURI pays more dividend than 97.18% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.23, CURI pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.13% |
5.2 History
CURI is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y37.49%
EPS Next 3Y27.13%
CURIOSITYSTREAM INC
NASDAQ:CURI (11/21/2024, 8:21:33 PM)
After market: 1.6198 0 (-0.01%)1.62
+0.03 (+1.89%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap89.88M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.13% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -16.89% | ||
| ROE | -23.77% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 48.4% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.9 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y75.51%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-8.56%
Revenue growth 3Y12.82%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y